Cite
Electrophysiological and ECG Effects of Perhexiline, a Mixed Cardiac Ion Channel Inhibitor, Evaluated in Nonclinical Assays and in Healthy Subjects.
MLA
Midei, Mark G., et al. “Electrophysiological and ECG Effects of Perhexiline, a Mixed Cardiac Ion Channel Inhibitor, Evaluated in Nonclinical Assays and in Healthy Subjects.” Journal of Clinical Pharmacology, vol. 61, no. 12, Dec. 2021, pp. 1606–17. EBSCOhost, https://doi.org/10.1002/jcph.1934.
APA
Midei, M. G., Darpo, B., Ayers, G., Brown, R., Couderc, J., Daly, W., Ferber, G., Sager, P. T., & Camm, A. J. (2021). Electrophysiological and ECG Effects of Perhexiline, a Mixed Cardiac Ion Channel Inhibitor, Evaluated in Nonclinical Assays and in Healthy Subjects. Journal of Clinical Pharmacology, 61(12), 1606–1617. https://doi.org/10.1002/jcph.1934
Chicago
Midei, Mark G., Borje Darpo, Greg Ayers, Randy Brown, Jean‐Philippe Couderc, William Daly, Georg Ferber, Philip T. Sager, and A. John Camm. 2021. “Electrophysiological and ECG Effects of Perhexiline, a Mixed Cardiac Ion Channel Inhibitor, Evaluated in Nonclinical Assays and in Healthy Subjects.” Journal of Clinical Pharmacology 61 (12): 1606–17. doi:10.1002/jcph.1934.